{
    "clinical_study": {
        "@rank": "120906", 
        "arm_group": {
            "arm_group_label": "K-Pat", 
            "arm_group_type": "Experimental", 
            "description": "Getting one time one hour of Khalifa's therapy for ACL injury treatment."
        }, 
        "brief_summary": {
            "textblock": "The primary hypothesis is that Khalifa's therapy has different acute effects in various\n      organ systems i.e. proprioceptive, neuro-muscular, endogenous dopamine system, etc. These\n      effects might indicate the pathway of the therapy."
        }, 
        "brief_title": "Khalifa Acute Effects", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Totally Ruptured Anterior Cruciate Ligament in the Knee", 
        "condition_browse": {
            "mesh_term": "Rupture"
        }, 
        "detailed_description": {
            "textblock": "According to our previous study that evaluated the efficacy of Khalifa's therapy the\n      investigators have seen that the therapy has acute effects which resulted in better knee\n      function and later even in better healing of the ACL injury. This study should clear exactly\n      which effects and pathways are involved in the therapy from multiple (interdisciplinary)\n      point of views. Therefore the investigators will measure parameters that might be associated\n      with this special technique directly before and after the therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  totally ruptured ACL - MRI verified, 2 weeks old as a maximum\n\n          -  knee function: Any functional inhibition (stretching, bending or load)\n\n          -  BMI: 18-25\n\n          -  athletically active\n\n        Exclusion Criteria:\n\n          -  any surgical procedures at the injured knee at any previous time\n\n          -  any acute surgical indication\n\n          -  diabetes mellitus and/or high blood pressure\n\n          -  any permanent drug treatment"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "49 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762371", 
            "org_study_id": "KhalSbg1"
        }, 
        "intervention": {
            "arm_group_label": "K-Pat", 
            "description": "One hour of Khalifa's therapy which is specially applied pressure to the skin.", 
            "intervention_name": "Khalifa Therapy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ACL", 
            "Knee", 
            "Ligament", 
            "Cruciate", 
            "Anterior"
        ], 
        "lastchanged_date": "January 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Hallein", 
                    "country": "Austria", 
                    "state": "Salzburg", 
                    "zip": "5400"
                }, 
                "name": "Sports Center of University Salzburg"
            }
        }, 
        "location_countries": {
            "country": "Austria"
        }, 
        "number_of_arms": "1", 
        "official_title": "Interdisciplinary Evaluation of Acute Effects From Khalifa's Therapy at Patients With Fully Ruptured Anterior Cruciate Ligament (ACL).", 
        "overall_official": [
            {
                "affiliation": "AKH Linz", 
                "last_name": "Andreas Kastner, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Med Uni Graz", 
                "last_name": "Andreas Sandner, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Austria: Ethikkommission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Perfusion", 
                "measure": "Laser Doppler-Flow", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Near infrared spectroscopy, Oxygen saturation", 
                "measure": "NIRS", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Infrared thermography, temperature", 
                "measure": "IR Thermography", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Quantitative sensoric testing, pain", 
                "measure": "QST", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Heart rate variability, sympathicus/parasympathicus activation", 
                "measure": "HRV", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Electroencephalogram, brain waves", 
                "measure": "EEG", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "IKDC Score KT-1000 test Clinical / physical examination", 
                "measure": "Knee function", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }, 
            {
                "description": "Posturomed Motion capture proprioception muscle power range of motion", 
                "measure": "SportsScience", 
                "safety_issue": "No", 
                "time_frame": "2 hours"
            }, 
            {
                "description": "Catecholamines endorphins standard blood parameters", 
                "measure": "Blood", 
                "safety_issue": "No", 
                "time_frame": "1 hour"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762371"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Medical University of Graz", 
            "investigator_full_name": "Andreas Sandner-Kiesling , MD", 
            "investigator_title": "Univ.Prof.Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Different questions about pain, lifestyle, subjective parameters", 
            "measure": "Questionnaire", 
            "safety_issue": "No", 
            "time_frame": "1 hour"
        }, 
        "source": "Medical University of Graz", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medical University of Graz", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}